Cargando…
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
Autores principales: | Danjuma, Mohammed I., Kaul, Ridhima, Alyaarabi, Tamader, Elsayed, Basant, Elshafei, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933322/ https://www.ncbi.nlm.nih.gov/pubmed/36804360 http://dx.doi.org/10.1016/j.ejim.2023.02.009 |
Ejemplares similares
-
Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses
por: Danjuma, Mohammed I., et al.
Publicado: (2023) -
Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021) -
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
COVID-19, colchicine and glycemia
por: Ilias, Ioannis, et al.
Publicado: (2021) -
Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine
por: Ghang, Byeongzu, et al.
Publicado: (2022)